Diabetes Self-Management Blog

“What We’re Reading” is a new feature on The Diabetes Self-Management Blog in which we highlight interesting posts on other diabetes blogs out there on the Web.

(What’s a blog, you ask? It’s short for “weblog,” and you’re reading one right now! Learn more about blogs from our earlier post on the topic.)

This week, we’d like to direct your attention to this post at diabetes.about.com about Wal-Mart’s new generic drug program, which will offer month-long supplies of 314 of the most commonly prescribed generic drugs for $4.00 apiece. This blog is written by Debra Manzella, a writer and practicing nurse.

“What We’re Reading” is a new feature on The Diabetes Self-Management Blog in which we highlight interesting posts on other diabetes blogs out there on the Web.

(What’s a blog, you ask? It’s short for “weblog,” and you’re reading one right now! Learn more about blogs from our earlier post on the topic.)

This week, we’d like to direct your attention to this post at diabetes.about.com about Wal-Mart’s new generic drug program, which will offer month-long supplies of 314 of the most commonly prescribed generic drugs for $4.00 apiece. This blog is written by Debra Manzella, a writer and practicing nurse.

POST A COMMENT       
  

Comments
  1. There are no comments at this time.


Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of Madavor Media, LLC., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.


What We're Reading
Take Part in the Big Blue Test! (10/23/14)
Free Webinar on Detecting Health-Care Errors and Fraud (10/17/14)
Ski and Snowboard Camps for Kids With Diabetes (10/06/14)
Project Blue November (10/06/14)

Oral Medicines
Statins May Reduce Risk of Nerve Damage, Other Diabetes Complications (09/18/14)
New Metformin Combo Drug Approved for Type 2 Diabetes (08/13/14)
FDA Approves New Oral Drug for Type 2 Diabetes (08/07/14)
New SGLT Drugs Coming (07/23/14)

Money Matters
Money Is Strong Diabetes Medicine (08/20/14)
Getting Real About Diabetes Food Advice (01/22/14)
Generic Drug Costs Can Be Crazy (01/15/14)
New Tool to Save Money on Medicines (05/22/13)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.